Effects of celecoxib on restenosis after coronary intervention and evolution of atherosclerosis trial
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Celecoxib (Primary) ; Paclitaxel; Zotarolimus
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms mini-COREA
- 08 Mar 2012 Primary endpoint 'Late-loss' has been met.
- 13 Aug 2007 New trial record.